Today: 7 February 2026
Subscribe

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

New York, Jan 5, 2026, 15:24 EST General Motors, Southwest Airlines and Tapestry ended 2025 with last-12-month buyback yields above 10% after repurchasing stock worth $8.2 billion, $2.75 billion and $2.8 billion, respectively, MarketBeat wrote on Monday. GM shares rose nearly 53% in 2025, while Southwest gained 23% and Tapestry climbed 96%, the report said. MarketBeat The renewed focus on buybacks comes as investors look for durable supports for equity returns at the start of a new year. Repurchases reduce the number of shares outstanding, which can lift earnings per share even when a company’s overall profit growth slows. That
5 January 2026
·······
Uber stock slips on Melius “Sell” call as robotaxi competition looms in 2026

Uber stock slips on Melius “Sell” call as robotaxi competition looms in 2026

New York, January 5, 2026, 15:27 ET — Regular session Uber Technologies, Inc. shares were down 1.9% at $81.30 in afternoon trading on Monday, after Melius Research downgraded the ride-hailing company to “sell” with a $73 price target. “Even with Uber’s position, AV competition is set to rise in 2026 and beyond,” Melius analyst Conor Cunningham wrote, referring to autonomous vehicles, or self-driving cars. Streetinsider The call is landing at the start of a year when investors are trying to gauge how quickly robotaxis move from pilots into broader commercial service. That matters for Uber because self-driving fleets could change
5 January 2026
····
Bloom Energy stock jumps again as traders refocus on its $600 million credit line

Bloom Energy stock jumps again as traders refocus on its $600 million credit line

New York, January 5, 2026, 15:20 EST — Regular session Bloom Energy shares rose about 5.9% to $104.50 in afternoon trade on Monday as investors weighed the fuel-cell maker’s access to fresh liquidity. The stock hit an intraday high of $107.24. The move matters because financing has become a key swing factor for fast-growing clean-energy companies that still face choppy cash flows. For Bloom, balance-sheet flexibility is under scrutiny as demand builds for on-site power systems tied to data centers and other large electricity users. A revolving credit facility is essentially a bank line of credit that a company can
5 January 2026
·····
Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

New York, January 5, 2026, 15:24 EST — Regular session Shares of Lumentum Holdings Inc fell about 7.6% on Monday, extending a selloff across parts of the optical networking space even as the broader U.S. equity market held higher. The slide matters because Lumentum has been one of the standout winners tied to the buildout of AI data centers, leaving little room for disappointment as investors refocus on valuation and the next set of results. Lumentum closed at $386.11 on Friday, close to the 52-week high of $401.60 it hit on Dec. 24, and the stock is up about 326.9%
5 January 2026
········
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The move followed two Form 144 filings that signaled planned sales by company affiliates. In smaller biotech names, even routine insider activity can sway short-term sentiment when liquidity is thinner. Form 144 is an SEC notice filed before certain holders sell stock under Rule 144, which governs resales of restricted or “control” shares. The filing does not confirm a sale, but
5 January 2026
····
HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

Bengaluru, Jan 6, 2026, 01:45 IST — Market closed HDFC Bank Limited’s share price fell 2.4% on Monday after its December-quarter update showed loans grew faster than deposits, putting the lender’s funding position back in focus. The stock closed at 977.5 rupees, while the Nifty 50 ended down 0.30% and the Sensex slipped 0.38% amid IT weakness and fresh U.S. tariff worries. Reuters The reaction matters now because deposit growth has lagged credit growth across India’s banking system, tightening funding and limiting how quickly lenders can expand loan books. India’s system loan-to-deposit ratio — a gauge of how much of
5 January 2026
····
Cisco stock dips as $2 billion Axonius takeover report fuels security M&A chatter

Cisco stock dips as $2 billion Axonius takeover report fuels security M&A chatter

New York, Jan 5, 2026, 15:19 EST — Regular session Cisco Systems Inc (CSCO.O) shares edged lower on Monday after an Israeli tech outlet reported the networking company is in talks to buy cybersecurity firm Axonius for about $2 billion, a deal Axonius publicly denied. ctech The report matters now because Cisco has been leaning harder into security and software to broaden growth beyond hardware, and asset visibility is a rising priority for large companies managing sprawling fleets of devices and cloud applications. A purchase would also keep attention on how Cisco deploys cash as dealmaking returns to parts of
5 January 2026
····
Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

New York, January 5, 2026, 15:22 EST — Regular session Xenon Pharmaceuticals Inc (XENE) shares were down 6.5% at $41.60 in afternoon trading on Monday, about 8% off the session high. The Nasdaq-listed biotech traded between $45.21 and $41.45, with roughly 787,000 shares changing hands. The slide comes with Xenon approaching a busy stretch of investor events and trial milestones ahead of next week’s J.P. Morgan Healthcare Conference, often a tone-setter for biotech trading. Xenon’s lead molecule, azetukalner, is in Phase 3 trials — late-stage studies typically used to support drug-approval filings — in epilepsy and mood disorders, and the
5 January 2026
·····
Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

New York, January 5, 2026, 15:09 EST — Regular session Shares of Spyre Therapeutics Inc fell 2.7% to $29.75 in afternoon trading on Monday, extending a choppy start to the year for smaller biotechnology names. The stock traded between $28.02 and $30.75, with about 0.63 million shares changing hands. The decline tracked weakness across the biotech complex, with the SPDR S&P Biotech ETF down 1.7% and the iShares Nasdaq Biotechnology ETF off 1.5%. Both are exchange-traded funds, meaning baskets of stocks that trade like a single share, while the SPDR S&P 500 ETF rose 0.7%, underscoring the sector’s underperformance. That
5 January 2026
····
Workday stock jumps after RBC keeps bullish call despite target cut; what investors watch next

Workday stock jumps after RBC keeps bullish call despite target cut; what investors watch next

New York, January 5, 2026, 15:08 EST — Regular session Workday Inc shares climbed about 2% on Monday, extending a rebound from early-session lows as a bullish analyst call helped steady sentiment around the cloud software maker. The stock was up $4.13 at $209.92 in afternoon trade. The move matters because Workday has been a pressure point in application software, where investors are debating how quickly corporate customers will turn new generative AI — software that produces content such as text and code — into measurable savings and spending plans. It also lands at the start of a new calendar
5 January 2026
·····
Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

New York, January 5, 2026, 14:56 EST — Regular session Shares of Nextpower Inc (NXT) fell 3.9% to $89.18 in afternoon trading on Monday, retreating from an opening print of $95.13 and an intraday high of $95.50. The stock last traded $3.60 below Friday’s close of $92.78. The Invesco Solar ETF (TAN) slipped 0.8%, while tracker peer Array Technologies (ARRY) fell 4.8%; First Solar (FSLR) eased 1.6% and solar electronics makers Enphase Energy (ENPH) and SolarEdge Technologies (SEDG) rose. The slide matters because it pulls Nextpower back toward a technical support zone — a chart level where buyers have tended
5 January 2026
········
Citigroup stock jumps to a fresh 52-week high as bank shares lead Wall Street rally

Citigroup stock jumps to a fresh 52-week high as bank shares lead Wall Street rally

New York, Jan 5, 2026, 15:00 EST — Regular session Citigroup Inc (NYSE: C) shares rose about 4% to $123.44 in afternoon trading on Monday, after touching a 52-week high of $124.05. The stock’s prior close was $118.70. Yahoo Finance The move puts Citi in sharper focus ahead of fourth-quarter results on Jan. 14, when the bank plans to issue its financial release around 8 a.m. ET and host a webcast at about 11 a.m. ET. JPMorgan Chase is expected to report a day earlier, on Jan. 13, before the market opens. Nasdaq Big banks broadly rose on Monday: JPMorgan
5 January 2026
·····
1 … 910 911 912 913 914 … 2,709

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop